CSII Cardiovascular Systems Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: CSII

Price (delayed)

$38.24

Market cap

$1.54B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.64

Enterprise value

$1.48B

Highlights
CSII's equity has surged by 89% year-on-year
CSII's quick ratio has soared by 79% YoY but it is down by 8% from the previous quarter
CSII's net income has plunged by 120% YoY and by 15% from the previous quarter
The EPS has plunged by 106% YoY and by 12% from the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://csi360.com/
Peers: ANGO LMAT BSX MMSI

Key stats

What are the main financial stats of CSII
Market
Shares outstanding
40.16M
Market cap
$1.54B
Enterprise value
$1.48B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
5.68
Price to sales (P/S)
6.45
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.42
Earnings
Revenue
$230.53M
EBIT
-$21.19M
EBITDA
-$17.02M
Free cash flow
-$17.75M
Per share
EPS
-$0.64
Free cash flow per share
-$0.46
Book value per share
$6.73
Revenue per share
$5.92
TBVPS
$8.51
Balance sheet
Total assets
$346.94M
Total liabilities
$76.48M
Debt
$20.66M
Equity
$270.45M
Working capital
$234.9M
Liquidity
Debt to equity
0.08
Current ratio
5.66
Quick ratio
4.94
Net debt/EBITDA
3.21
Margins
EBITDA margin
-7.4%
Gross margin
78%
Net margin
-10.1%
Operating margin
-9.4%
Efficiency
Return on assets
-6.8%
Return on equity
-8.6%
Return on invested capital
-10.9%
Return on capital employed
-7.1%
Return on sales
-9.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CSII stock price

How has the Cardiovascular Systems stock price performed over time
Intraday
-5.09%
1 week
-2.5%
1 month
-10.36%
1 year
25.46%
YTD
-12.61%
QTD
-10.34%

Financial performance

How have Cardiovascular Systems's revenue and profit performed over time
Revenue
$230.53M
Gross profit
$179.89M
Operating income
-$21.75M
Net income
-$23.3M
Gross margin
78%
Net margin
-10.1%
The net margin has plunged by 153% YoY and by 15% from the previous quarter
CSII's operating margin has dropped by 129% year-on-year and by 15% since the previous quarter
CSII's net income has plunged by 120% YoY and by 15% from the previous quarter
CSII's operating income has dropped by 102% year-on-year and by 15% since the previous quarter

Growth

What is Cardiovascular Systems's growth rate over time

Valuation

What is Cardiovascular Systems stock price valuation
P/E
N/A
P/B
5.68
P/S
6.45
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.42
The EPS has plunged by 106% YoY and by 12% from the previous quarter
CSII's equity has surged by 89% year-on-year
CSII's P/B is 28% lower than its 5-year quarterly average of 7.9 but 3.3% higher than its last 4 quarters average of 5.5
The P/S is 24% more than the 5-year quarterly average of 5.2 and 2.4% more than the last 4 quarters average of 6.3
Cardiovascular Systems's revenue has decreased by 12% YoY

Efficiency

How efficient is Cardiovascular Systems business performance
The ROS has plunged by 179% YoY and by 16% from the previous quarter
The ROA has decreased by 42% YoY and by 4.6% QoQ
Cardiovascular Systems's return on invested capital has decreased by 40% YoY
The company's return on equity fell by 16% YoY

Dividends

What is CSII's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CSII.

Financial health

How did Cardiovascular Systems financials performed over time
CSII's quick ratio has soared by 79% YoY but it is down by 8% from the previous quarter
Cardiovascular Systems's current ratio has surged by 72% YoY but it has decreased by 7% QoQ
The debt is 92% less than the equity
CSII's equity has surged by 89% year-on-year
Cardiovascular Systems's debt to equity has decreased by 47% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.